| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,180,000 |
| Market
Cap: |
7.45(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2315 - $0.2315 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Motus GI Holdings has developed the Pure-Vu System, a medical device that has been cleared to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide exams.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sherman Darren |
Director |
– • – |
2018-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,000,000 |
2,000,000 |
|
- |
|
| Sherman Darren |
Director |
– • – |
2018-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000,000) |
109,792 |
|
- |
|
| Jacobs Gary E. |
Director |
– • – |
2018-05-18 |
4 |
B |
$5.24 |
$26,200 |
I/I |
5,000 |
728,856 |
2.1 |
- |
|
| Sherman Darren |
Director |
– • • |
2018-05-17 |
4 |
B |
$5.55 |
$5,550 |
D/D |
1,000 |
9,000 |
3.84 |
- |
|
| Hochman David P |
Chairman of the Board |
– • • |
2018-05-17 |
4 |
B |
$5.49 |
$27,450 |
I/I |
5,000 |
80,000 |
2.25 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2018-02-16 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
2,800,541 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
256,386 |
1,800,541 |
|
- |
|
| Hochman David P |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
164,786 |
1,159,968 |
|
- |
|
| Hochman David P |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
B |
$5.00 |
$200,000 |
I/I |
40,000 |
1,010,044 |
2.25 |
- |
|
| Hochman David P |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
78,000 |
|
- |
|
| Hochman David P |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
B |
$5.00 |
$375,000 |
D/D |
75,000 |
77,250 |
3.92 |
- |
|
| Ascent Biomedical Ventures Ii, L.p. |
10% Owner |
– – • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
144,352 |
1,591,481 |
|
- |
|
| Pomeranz Mark |
Chief Executive Officer |
• • – |
2018-02-16 |
4 |
B |
$5.00 |
$40,000 |
D/D |
8,000 |
8,141 |
2.81 |
- |
|
| Taylor Andrew Lawrence |
Chief Financial Officer |
• – – |
2018-02-16 |
4 |
B |
$5.00 |
$10,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Abv, Llc |
10% Owner |
– – • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
170,593 |
611,241 |
|
- |
|
| Jacobs Gary E. |
Director |
– • – |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
63,289 |
723,856 |
|
- |
|
| Jacobs Gary E. |
Director |
– • – |
2018-02-16 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
9,100 |
2.39 |
- |
|
| Pruden Gary J |
Director |
– • – |
2018-02-16 |
4 |
B |
$5.00 |
$250,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| Korangy Shervin J |
Director |
– • – |
2018-02-16 |
4 |
B |
$5.00 |
$100,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Nussbaum Samuel R Md |
Director |
– • – |
2018-02-16 |
4 |
B |
$5.00 |
$50,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Sherman Darren |
Director |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
164,786 |
1,159,968 |
|
- |
|
| Sherman Darren |
Director |
– • • |
2018-02-16 |
4 |
B |
$5.00 |
$200,000 |
I/I |
40,000 |
1,010,044 |
2.25 |
- |
|
| Sherman Darren |
Director |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
8,000 |
|
- |
|
| Sherman Darren |
Director |
– • • |
2018-02-16 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
7,250 |
3.92 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2018-02-14 |
4 |
B |
$5.00 |
$50,000 |
I/I |
10,000 |
2,810,541 |
1.5 |
- |
|
112 Records found
|
|
Page 4 of 5 |
|
|
